Skip to main content
logo
Neovacs S.A. (EPA:ALNEV)
France flag France · Delayed Price · Currency is EUR
0.6120
-0.0680 (-10.00%)
Aug 21, 2026, 5:35 PM CET

Neovacs Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Aug '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Last Close Price
0.6110212000.0020000.00336000.0040000.002416000.00

Financial Efficiency

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Aug '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Debt / Equity Ratio
0.010.010.010.020.020.04
Net Debt / Equity Ratio
0.01-0.010.00-0.11-0.73-0.88
Net Debt / EBITDA Ratio
-0.020.030.040.884.152.82
Net Debt / FCF Ratio
-0.040.060.111.213.131.65
Asset Turnover
0.010.010.0100.000.00
Quick Ratio
0.650.620.992.5315.606.11
Current Ratio
0.670.651.032.6815.646.20
Return on Equity (ROE)
-23.23%-98.39%-17.66%-7.54%-43.11%-88.72%
Return on Assets (ROA)
-10.66%-11.09%-8.00%-7.76%-15.76%-20.63%
Return on Capital Employed (ROCE)
-30.00%-36.30%-14.10%-12.40%-16.90%-30.60%

Yields

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Aug '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Buyback Yield / Dilution
----12025.88%99.70%-327.36%